ANDOVER, Mass., July 22, 2021 /PRNewswire/ -- TransMedics
Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology
company that is transforming organ transplant therapy for patients
with end-stage lung, heart and liver failure, today announced that
it will release financial results for the second quarter after
market close on Thursday, August 5,
2021. The TransMedics management team will host a
corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m.
PT.
Investors interested in listening to the conference call may do
so by dialing (833) 378-1026 for domestic callers or (236) 712-2500
for international callers, followed by Conference ID: 9861546. A
live and archived webcast of the event will be available on the
"Investors" section of the TransMedics website at
https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the
world's leader in portable extracorporeal warm perfusion and
assessment of donor organs for transplantation. Headquartered in
Andover, Massachusetts, the
company was founded to address the unmet need for more and better
organs for transplantation and has developed technologies to
preserve organ quality, assess organ viability prior to transplant,
and potentially increase the utilization of donor organs for the
treatment of end-stage heart, lung, and liver failure.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-second-quarter-2021-financial-results-on-august-5-2021-301339711.html
SOURCE TransMedics Group, Inc.